Stephan Siegel
Inventor
Stats
- 10 US patents issued
- 33 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 10 US Patents Issued
- 33 US Applications Filed
- 124 Total Citation Count
- Aug 31, 2023 Most Recent Filing
- Jul 20, 2004 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SIEMENS MEDICAL SOLUTIONS USA, INC. | 1
| 2015
|
Bayer Aktiengesellschaft | 1
| 2004
|
SAXONIA EUROCOIN GMBH | 1
| 2014
|
CRANE PAYMENT INNOVATIONS GMBH | 1
| 2014
|
BAYERISCHES HAUPTMUENZAMT | 1
| 2014
|
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT | 1
1 2 1 | 2004
2007 2008 2009 |
BAYER INTELLECTUAL PROPERTY GMBH | 6
4 3 3 | 2008
2009 2012 2013 |
BAYER HEALTHCARE AG | 3
1 | 2004
2008 |
BAYER PHARMA AKTIENGESELLSCHAFT | 1
4 1 | 2010
2013 2015 |
STAATLICHE MUENZEN BADEN-WUERTTEMBERG | 1
| 2014
|
Inventor Addresses
Address | Duration |
---|---|
Berlin, DE | May 06, 10 - Sep 19, 24 |
Dresden, DE | May 29, 14 - Jan 11, 18 |
Knoxville, TN, US | Apr 11, 17 - Apr 11, 17 |
Winnenden, DE | Mar 09, 23 - Mar 09, 23 |
Wuppertal, DE | Feb 24, 05 - Apr 29, 10 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 4 |
A44C: | JEWELLERY; BRACELETS; OTHER PERSONAL ADORNMENTS; COINS | 1 |
A47L: | DOMESTIC WASHING OR CLEANING | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0307,362 | 2024 | 4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS | 0 |
2024/0150,277 | 2024 | Covalent PPARG inverse-agonists | 0 |
2023/0416,249 | 2023 | N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | 0 |
2023/0075,130 | 2023 | SUCTION APPARATUS | 0 |
2023/0064,983 | 2023 | 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.